Skip to content

Nasal High Flow Versus Conventional Therapy in Emergency Department Patients With Asthma Exacerbation: A Randomized Controlled Trial

Nasal High Flow Versus Conventional Therapy in Emergency Department Patients With Asthma Exacerbation: A Randomized Controlled Trial

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210416004
Enrollment
80
Registered
2021-04-16
Start date
2021-04-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute asthma exacerbation asthma attack acute severe asthma asthma exacerbation

Interventions

High flow therapy is delivered by Optiflow cannula using an AIRVO flow source (Fisher &amp
Paykel Healthcare Ltd). The initial flow will be set at 30 L/min and can be increased 5 L/min every 15 minutes up to 60 L/min if tolerable. FiO2 will be adjusted to keep oxygen saturation by pulse oxi
Experimental Device,No Intervention No treatment
High-flow nasal cannula,Conventional therapy

Sponsors

Siriraj Research and Development Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with age of 18 years or older 2. Patients previously diagnosed with asthma according to GINA guideline6 3. Patients who present with symptoms compatible with exacerbation according to GINA guideline6 (progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness and progressive decrease in lung function) 4. Patients who are still eligible meeting the above three criteria after initial standard management for 60 minutes

Exclusion criteria

Exclusion criteria: 1. Patients with respiratory failure; defined as respiratory rate > 35 breaths/min, SpO2 < 90% despite oxygen supplement or signs of increased work of breathing, as observed by use of accessory muscles and abdominal asynchrony. 2. Patients with hemodynamic compromise (blood pressure < 90/60 mmHg) despite intravenous fluid resuscitation 3. Patients with a Glasgow Coma Scale score less than 13 4. Patients with contraindications to the use of equipment with positive airway pressure 5. Patients previously diagnosed with COPD or other chronic lung disease such as interstitial lung disease 6. Patients previously smoking > 5 pack/year 7. Patients concurrently diagnosed with other lower airway conditions such as pneumonia, pulmonary edema 8. Patients who decline to participate 9. Pregnant patients

Design outcomes

Primary

MeasureTime frame
the degree of dyspnea measured with modified Borg scale 2 hours Questionnaire completed by the participant

Secondary

MeasureTime frame
the degree of dyspnea measured with numeric rating scale 2 hours Questionnaire completed by the participant,Respiratory rate 2 hours automated machine,oxygen saturation 2 hours automated machine,end-tidal carbondioxide 2 hours automated machine,pulse rate 2 hours automated machine,blood pressure 2 hours automated machine,the degree of dyspnea measured with visual analog scale 2 hours rate by the study investigators,peak expiratory flow rate 2 hours peak flow meter,treatment escalation 24 hours prospective observation,Adverse events hospital stay prospective observation,length of stay hospital stay prospective observation

Countries

Thailand

Contacts

Public ContactOnlak Ruangsomboon

Department of Emergency Medicine, Siriraj Hospital, Mahidol University

doctor.mo@yahoo.com0877853385

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026